A Case of Iliopsoas Hematoma Caused by Prophylactic Anticoagulation against COVID-19

BACKGROUND: COVID-19 is associated with an increased risk of venous thromboembolism (VTE), and prophylactic anticoagulation is recommended for the prevention of VTE in COVID-19 patients. We encountered a patient with COVID-19 who developed iliopsoas hematoma (IPH) that was likely caused by prophylac...

Descripción completa

Detalles Bibliográficos
Autores principales: Masaki, Shoichi, Takahashi, Tadashi, Sahara, Toshinori, Endo, Ryo, Obana, Masayoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JARM 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811153/
https://www.ncbi.nlm.nih.gov/pubmed/35178482
http://dx.doi.org/10.2490/prm.20220004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811153/
https://www.ncbi.nlm.nih.gov/pubmed/35178482
http://dx.doi.org/10.2490/prm.20220004

Ejemplares similares